Revolution Medicines’ drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.
South Korea, US agree that Korean won’s excessive volatility not desirable
...
Read moreDetailsHome » Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage trial
Revolution Medicines’ drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.